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ABSTRACT 
 
 The use of biological products such as platelet-rich plasma (PRP) and mesenchymal 
stem cels (MSCs)  has  become an incredibly  promising and advantageous  product in 
modern regenerative therapeutics.  The  occurence  of incisional  herniation folowing 
invasive abdominal surgeries remains a  particularly complicating issue in post-surgery 
recovery with about  10%  of  patients experiencing  herniation folowing laparotomy 
(Bucknal et al., 1982). This study aims to provide a cel-based therapy for the treatment 
of surgical wounds and enhance healing. Using a rat model, bone marow-derived MSCs 
(BM-MSCs),  PRP, and a colagen scafold (ColaTape) are applied to the surgical site 
folowing an abdominal laparotomy.  The rats were alowed to heal for 4 weeks before 
tissue samples  of the  wound site  were  harvested to analyze wound characteristics. 
Histological examination  of  wound sites treated  with  BM-MSCs indicates important 
information for  diferences in specific events involved in the  wound  healing  process 
including colagen deposition, connective tissue organization, and muscle regeneration. It 
was found that applying PRP and ColaTape to the abdominal incisions was able to increase 
colagen abundance and stimulate new muscle growth. The application of MSCs to the 
injury was able to further enhance the deposition of organized colagen fibers in a dose-
dependent manner. Additionaly, characteristics of the BM-MSCs, including their ability 
to diferentiate into chondrogenic, adipogenic, and osteogenic cel lineages was performed 
in order to exhibit their stem potential. 
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INTRODUCTION 
REGENERATIVE)MEDICINE)
Regenerative medicine involves the ability to restore or replace cels, tissues, or 
organs to reinstate or establish normal tissue function. This course of clinical therapeutics 
represents an incredibly diverse and emergent field with expanding capabilities.  Through 
regenerative  medicine, efective treatments are  being  developed for countless  medical 
pathologies. 
 The  methods and strategies  utilized in regenerative therapies  hold a tremendous 
capacity for the amelioration  of  wound  healing.   Using cel-based techniques, an 
individual’s  own repair  mechanisms can  be stimulated to  mend  or fix  damaged tissues. 
Furthermore, cels, tissues, or even organs can be grown in vitro and used to replace those 
which are  damaged,  diseased, or improperly functioning.   This ability  bypasses the 
necessity for  organ  donation and reduces the risk for rejection, since the tissues can 
essentialy be individualized for each person or entity. The primary goal for regenerative 
medicine lies in the understanding of disease mechanisms, so that they may be exploited 
to bring about a desired result and aid in the repair of tissues. 
At present, regenerative medicine relies heavily on the use of stem cels, other types 
of multipotent cels, and various biological products. This includes mesenchyme-derived 
cels such as  mesenchymal stromal/stem cels (MSCs) and  blood isolate  products like 
platelet-rich  plasma (PRP).  The term “mesenchymal stromal cel” is  often  used 
interchangeably with “mesenchymal stem cels” since there is a bit of controversy over 
whether certain cel populations can in fact be caled stem cels. However, for the remainder 
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of this article, when using the abbreviation “MSCs” it wil refer to “mesenchymal stem 
cels” and not “mesenchymal stromal cels”. MSCs and PRP are of particular interest in 
one area of regenerative medicine, wound repair, since they may be easily obtained and 
have a large influence on the process of healing. MSCs and PRP can induce cel migration 
to  wound sites and stimulate the  proliferation and  diferentiation  of these cels through 
secreted trophic factors (Chen et al.,  2008).   MSCs also  possess immunomodulatory 
properties  which could  prove to  be  very  beneficial for the treatment  of tissue rejection 
folowing transplantation, as wel as therapy for some autoimmune reactions (Lee et al., 
2015). The lack of immunogenicity of MSCs, even when the cels come from diferent 
individuals (alogeneic) or diferent species (xenogeneic) indicates a capacity for the cels 
to be used in widespread clinical applications (Gutierez-Fernandez et al., 2015; Ryan et 
al., 2005). 
WHAT)ARE)MESENCHYMAL)STEM)CELLS?)
Mesenchymal stromal cels are a  diverse  population undiferentiated,  plastic-
adherent cels with a fibroblast-like growth morphology which contain MSCs (Dominici 
et al., 2006).  Bone marow would include populations of both mesenchymal stromal and 
mesenchymal stem cels. The nomenclature of these multipotent cels is rather convoluted, 
as it is quite dificult to utilize any one term to fuly encompass their functional properties. 
Mesenchyme is an embryonic tissue that can diferentiate into hematopoietic or connective 
tissues. However, MSCs cannot diferentiate into hematopoietic cels except macrophages 
in some instances (Freisinger et al., 2010).  Stromal cels, in general, are defined as the 
connective tissue cels that form the supporting framework which make up an organ. For 
example, fibroblasts are stromal cels which produce the extracelular matrix and colagen 
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that form the structure for various organs. While this may adequately describe one function 
of  MSCs, it  does  not address their role in  wound  healing and ability for  multipotent 
diferentiation.  A  defining characteristic  of stem cels includes their  plastic-adherent 
capability and capacity for indefinite self-renewal in vitro, which means they can undergo 
numerous cycles of cel division while retaining an undiferentiated status (Dominici et al., 
2006). The manipulation of culture conditions cels can then be utilized to induce the cels 
to diferentiate into a certain cel type (Vater et al., 2011). Curent evidence suggests that 
some  of the cells in a  population  of  MSCs may lack the ability for self-renewal and 
diferentiation; therefore, they do not fit the complete description for “stem” cels (Horwitz 
et al., 2005). Thus the terms “stem” and “stromal” both fail to fuly characterize these cel 
populations. The International Society for Celular Therapy (ISCT) have recommended 
that “multipotent  mesenchymal stromal cel” is the corect terminology for the  plastic-
adherent cels isolated from bone marow and other tissues, rather than the term “stem” 
cel in order to reduce confusion and reserve the term “mesenchymal stem cel” for cels 
which meet the criteria for stem cel activity (Dominici et al., 2006). The diferentiation 
of the cels into various lineages and detection of certain cel surface protein markers are 
the de facto methods for exhibiting the stem potential of cels growing in culture. 
Curently there are no specific cel surface markers identified for only MSCs. The 
methodology for  MSC isolation and expansion can  vary, sometimes  quite significantly 
between laboratories. As a consequence of using diferent methods and assorted animal 
strains, cel surface  marker expression can  be inconsistent and  quite  heterogeneous 
(Haggman et al.,  2013).   Because  of this, accurate comparisons between experimental 
results can be dificult and standardization for identifying MSCs is necessary. The ISCT 
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has provided standards to define MSCs for greater consistency in the identification and 
designation of these cels (Dominici et al., 2006). There are three minimal criteria for the 
definition of MSCs: (1) the cels are plastic-adherent under standard culture conditions; (2) 
greater than 95% of the cels exhibit positive expression for the cel-surface protein markers 
CD105 (endothelial cels), CD73 (folicular  dendritic cels, epithelial, and endothelial 
cels), and CD90 (hematopoietic stem cels); while less than 2% of the cels are positive 
for  CD45 (hematopoietic cels),  CD34 (hematopoietic stem/progenitor cels),  CD14 
(monocytes, macrophages, B cels, dendritic cels, hepatocytes) or CD11b (granulocytes, 
monocytes,  NK cels,  myeloid  dendritic cels),  CD79α (B cels)  or  CD19 (folicular 
dendritic cels), and HLA class I (triggers T lymphocyte activation); (3) The cels must be 
able to  diferentiate into  osteocytes, adipocytes, and chondrocytes  under standard 
conditions (Dominici et al., 2006). 
MSCs  hold  particular  promise for clinical applications, tissue engineering and 
regenerative medicine due to certain inherent properties. They can be easily obtained from 
bone  marow and various  other sources including adipose tissue,  peripheral  blood, 
umbilical cord blood, and connective tissues have been identified as reservoirs for these 
cels (Haggman et al., 2013). MSCs retain a state of multipotency, which means they have 
the ability to undergo diferentiation into more specialized and mature cels types (Sasaki 
et al., 2008; Chen et al., 2014). Furthermore, they have exhibited an ability to promote 
wound  healing and tissue renewal  while also supporting cel engraftment and immune 
modulation (Chen et al., 2012). 
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PLATELET4RICH)PLASMA)
Concentrated blood platelets are yet another autologous component which is being 
studied for its  potential in tissue repair.  When blood cloting  occurs at a  wound site, 
platelets degranulate to release bioactive growth factors. The growth factors secreted from 
platelets  bind to receptors  on  MSCs,  osteoblasts, fibroblasts, endothelial cels, and 
epidermal cels to induce cel processes such as proliferation and tissue synthesis (Marx 
2004).  
PRP USE IN CELL MEDIA  
It has been suggested that PRP, which is blood plasma with a high concentration of 
autologous platelets, can be used as an alternative serum source for the expansion of MSCs 
to be utilized in clinical applications (Goedecke et al., 2011).  This means that platelets 
obtained from the same individual can be used during cel expansion in place of serum 
from  other species, such as a fetal  bovine serum, to reduce immunogenicity  during 
subsequent therapy. The use of human platelet lysate in place of fetal bovine serum during 
cel expansion has been shown to induce no modifications of MSC immunophenotype or 
diferentiative capacity. However, diferences in cytokine expression were apparent and 
MSCs expanded in  media containing  platelet lysate secreted a  higher amount  of IL-6 
(inflammatory cytokine) and IL-8 (acts as a chemoatractant for  granulocytes and 
stimulates the formation of new blood vessels) (Azouna et al., 2012). 
THE TROPHIC EFFECTS OF PRP 
PRP is known to contain multiple growth factors which induce MSC proliferation 
and migration (Goedecke et al., 2011). There are seven principle growth factors that are 
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released by platelets which induce healing: three isomers of platelet-derived growth factor 
(PDGFαα, PDGFββ, and PDGFαβ), two types of transforming growth factors-β (TGFβ1 
and  TGFβ2),  vascular endothelial  growth factor (VEGF), and epidermal  growth factor 
(EGF) (Marx 2004). PDGF is a protein that regulates cel growth and division and acts as 
a potent mitogen for undiferentiated mesenchymal cels. Both PDGF and VEGF play a 
significant role in  promoting the formation  of  blood  vessels through angiogenesis, an 
important process necessary to restore blood flow to damaged tissues (Wu et al., 2007b). 
EGF  promotes cel  growth,  proliferation, and  diferentiation  of  various cels, including 
fibroblasts, mesenchymal cels, and endothelial cels (Berlanga-Acosta 2009). TGF-β also 
causes increased cel  proliferation.  Along  with a  high concentration  of soluble factors, 
PRP also  provides cel adhesion  molecules such as fibrin, fibronectin, and  vitronectin 
which aid in cel migration and the process of wound healing (Lubkowska et al., 2012). 
BONE)MARROW4DERIVED)MSCS)
Bone  marow-derived  mesenchymal stromal cels (BM-MSCs) are clonal 
precursors for non-hematopoietic mesodermal cels. Given specific conditions, MSCs can 
diferentiate both in vitro and in vivo (folowing transplantation) into multiple cel types. 
These include adipocytes,  osteoblasts, chondrocytes, fibroblasts, skeletal and cardiac 
myocytes, endothelial cels, and neurons (Jiang et al., 2002). Normaly MSCs can leave 
the marow and enter the systemic circulation in response to tissue damage (Sasaki et al., 
2008).   They can subsequently migrate to the specific site  of injury. Bone  marow is 
typicaly viewed as an easily obtainable source for MSCs since they may be readily isolated 
and expanded in vitro despite being found in only smal quantities. 
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Many investigations have demonstrated the therapeutic capacity of BM-MSCs in 
repairing or regenerating damaged tissues in almost al of the major organs of the body, 
including the brain, heart, lung, liver, eye, kidney, and skin (Hocking and Gibran, 2010). 
The diverse uses for MSC therapy indicates a vast potential for clinical applicability.  
HETEROGENEITY IN MSC POPULATIONS 
MSC  populations  display considerable heterogeneity  when it comes to 
morphological,  diferentiative, and  proliferative  properties (Azouna et al.,  2012).   Bone 
marow itself consists  of several diferent types  of adherent cels, including  osteogenic 
cels,  phagocytic cels, and endothelial cels.   Thus, these  other adherent cels could 
potentialy contaminate MSC cultures. Furthermore, cel surface protein expression has 
been shown to  vary  between  diferent cel  populations, likely  due to  diferences in cel 
isolation and expansion  procedures,  making it even  more  dificult to  properly identify 
MSCs (Hagmann et al., 2013). Additionaly, diferences have even been found in MSCs 
from the  bone  marow  of  diferent strains  of inbred  mice, even  when  using identical 
isolation and expansion protocols (Peister et al., 2004). The heterogeneous quality of these 
stromal cels adds a level of complexity and uncertainty for their use in clinical setings, 
and it is something that must be addressed in order to introduce standardized procedures 
involving MSCs as treatments for certain pathologies and conditions. 
EFFECTS OF MEDIA ON MSCS 
MSCs are found in low  quantities from  harvested  primary  bone  marow so it is 
necessary to isolate and expand the cels in vitro for later use. Curently, the expansion of 
MSCs relies  heavily  on the  utilization  of animal-based serum.   The addition  of animal 
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serum adds an inherent risk  of exposure to  disease causing agents and to  xenogeneic 
proteins. There is a motivation to eliminate the use animal-derived additives and instead 
utilize serum-free  media supplemented  with alternative additives such as  platelet lysate 
solutions. By eliminating the use of serum while during preparation of MSCs, the risk for 
immunogenic reactions and rejection of xenogeneic materials can be significantly reduced. 
Additionaly,  diferences  between animal serum sources  prevents  methodological 
standardization that is necessary for the extensive use of MSCs in clinical applications. 
Further contributing to cel heterogeneity, expansion media has been shown to alter 
the proteomic profile of human MSCs (Hocking and Gibran, 2010), as wel as their growth 
characteristics and diferentiation potential (Haggman et al., 2013). MSCs are influenced 
by signals resulting from culture conditions and factors such as cel seeding density, growth 
media, and added media supplements, which can compound the amount of heterogeneity 
the cel populations exhibit. 
CUTANEOUS)WOUND)HEALING)
MSC therapy is of particular interest for the promotion of cutaneous wound healing. 
A critical part of reforming viable tissue at wound sites is the proper reorganization of the 
underlying colagen fibers which increase dermal tissue strength and thus decrease the 
likelihood for rupture of a healed wound (Lokmic et al., 2006). Ideal healing of cutaneous 
injuries involves intricate and wel-coordinated celular and molecular mechanisms. MSCs 
can influence those complex  processes at  wound sites to bring about improved tissue 
regeneration (Jeon et al., 2010; Sasaki et al., 2008; McFarlin et al., 2006).  
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THE PHASES OF CUTANEOUS WOUND HEALING 
The  progression  of typical  wound  healing involves a complex succession  of 
reactions. The molecular events occuring at wound sites can essentialy be divided into 
four overlapping sequential phases with undefined beginnings and ends. The phases are: 
coagulation, inflammation,  migration/proliferation, and remodeling.   The first  phase, 
coagulation,  occurs almost immediately folowing injury and involves a cascade  of 
molecular and celular  mechanisms  which  bring about  hemostatic control  via  platelet 
degranulation and release of cloting factors. Blood platelets become embedded in clumps 
of fibrous proteins such as fibronectin, vitronectin, and fibrin that stops bleeding and forms 
an initial barier to prevent infection. These protein aggregates also provide a matrix for 
cel adhesion and migration during the folowing healing phases.  
Directly folowing  hemostatic control, the inflammatory  phase  occurs.   The 
platelets also release growth factors, including  PDGF and  TGF,  which  begin the 
recruitment of inflammatory and structural cels such as fibroblasts and endothelial cels to 
the wound site (Falanga 2005). Inflammatory cels recruited to the injury have multiple 
purposes including the neutralization and elimination of foreign pathogens. In addition, 
neutrophils and  macrophages secrete  mediators that stimulate the  growth  of connective 
tissue and also assist in debridement of the wound (Falanga 2005). Damage to blood vessels 
folowing cutaneous injury results in decreased oxygen availability to the  wound 
microenvironment due to reduced blood flow. The local state of hypoxia at the wound site 
actualy induces the  migration  of  various cels, such as fibroblasts and  keratinocytes 
(Falanga 2005). However, prolonged hypoxia causes excessive inflammation, leading to 
increased oxidative stress which may impair healing resulting in a chronic wound (Zou et 
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al., 2012). The disproportionate degree of inflammation resulting from persistent hypoxia 
can also cause disorganization in the synthesis of new connective that forms the granulation 
tissue which provide preliminary wound closure (Zou et al., 2012). Extended hypoxia can 
also result in the impairment  of  vessel  perfusion  during angiogenesis and delay 
reepithelialization  necessary for contraction (the movement  of  wound edges toward a 
center point to accomplish closure of a cutaneous injury) (Zou et al., 2012). 
As the inflammation stage diminishes, the recruited fibroblasts and endothelial cels 
begin to form  granulation tissue  which begins the  process  of  wound contraction. 
Contraction  occurs through the synthesis  of  granulation tissue,  vasculature, and 
extracelular  matrix (ECM).   The  ECM is the structural  material  made  up largely  of 
colagen, elastin, and  proteoglycans that surounds cels.  It is also very useful for cel 
adhesion. New blood vessels are formed to restore oxygen and nutrient alocation to the 
cels. The formation of new vasculature from existing blood vessels is an important aspect 
of wound repair to replace those damaged at the wound site and to restore blood supply. 
This  process, caled  neovascularization, is essential to  provide  damaged tissue  with 
nutrients and  oxygen,  plus the circulating cels and factors necessary for healing. 
Neovascularization can occur either by angiogenesis, where endothelial cels located at the 
wound site  proliferate and form  new  vessels,  or through  vasculogenesis,  where 
systemicaly circulating  progenitor cels are  directed to the  wound site and  begin the 
formation of producing completely new vasculature (Sasaki et al., 2008).  
The formation  of ECM in the initial stages  of  healing serves to  provide early 
stability for the wound and to act as a medium for cel migration.  However, the initial 
extracelular matrix does not provide adequate structural integrity to the healing wound, so 
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it is subsequently degraded by proteolytic enzymes. Large deposits of colagen are then 
put in place of ECM; first type II colagen and then later type I colagen (Lokmic et al., 
2008).   Type II colagen can  be  quickly  made,  however it is  mechanicaly  weaker 
(Henriksen et al.,  2010).   The type I colagen that replaces it forms  much stronger 
connections to enhance the integrity of the resulting scar. The colagen fibers can then be 
reorganized  by  dermal fibroblasts to further increase the tensile strength  of the  newly 
formed tissue during the tissue remodeling phase (Lokmic et al., 2008). 
CHRONIC WOUNDS 
If the process directing wound repair is interupted, cutaneous injuries wil fail to 
heal, triggering the formation  of chronic  non-healing  wounds.   Typicaly,  non-healing 
wounds  do  not folow the  natural  progression  of  healing.   Furthermore,  portions  of the 
wound may be unsynchronized with other parts, so several diferent phases of the healing 
process are occuring simultaneously. Dysregulation and inhibition of wound contraction 
frequently occur in wounds exhibiting pathophysiological abnormalities (Zou et al., 2012). 
This causes non-healing wounds to often be quite heterogeneous in nature. Dysfunction of 
the molecular mechanisms occuring in wound healing may alter the normal inflammatory 
events and  prevent  mesenchymal cel  proliferation,  diferentiation,  or  migration to the 
wound (Zou et al., 2012). Angiogenesis, reepithelialization, and appropriate alignment of 
colagen fibers may also be hindered (Zou et al., 2012). 
There are a multitude of factors that may contribute to the pathogenesis of impaired 
wounds, including a reduction in the  proliferation and  migration  of fibroblasts and 
keratinocytes. Since there are so many aspects which may be contributing to the chronic 
pathology, it is dificult to identify and address  one  problem at a time.    Even  with the 
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utilization of curent treatments such as physical debridement, hyperbaric oxygen therapy, 
and antibiotics, chronic wounds often remain unresponsive and wil not undergo normal 
healing  processes (Zou et al.,  2012).   At  best,  modern treatments can  only induce the 
closure of chronic wounds with a success rate of about 50% (Chen et al, 2008). Cels in 
non-healing  wounds  may  be fundamentaly impaired and  may exhibit  higher rates  of 
senescence and less sensitivity to  growth factor stimulation (Chen et al.,  2012).   Since 
curent remedies for chronic wounds are inefective in many cases, novel treatments are 
needed. 
Those sufering from chronic diseases, such as diabetes, are particularly susceptible 
to the  development  of  non-healing  wounds.   There are  more than  150  milion  people 
diagnosed with diabetes and, of these, 15% experience chronic wounds (Chen et al., 2008). 
With an increasing  prevalence  of type I  diabetes  melitus, the creation  of  dynamic 
treatments for chronic wounds is becoming more and more important.  The use of cel-
based therapies represents an incredibly  promising therapeutic approach  which  may 
significantly increase  wound closure.   For example, realization  of the importance for 
growth factor stimulation in healing has led to topical applications of regulatory proteins 
such as PDGF (found in PRP) which were able to increase wound closure (Falanga 2005). 
Ultimately, understanding the mechanisms of wound repair wil alow the development of 
new approaches in treating cutaneous injuries. 
THE)ROLE)OF)MSCS)IN)TISSUE)REGENERATION))
MSCs can be naturaly signaled to leave the bone marow and enter the systemic 
circulation where they are subsequently directed via molecular mechanisms to wound sites. 
These  multipotent cels  have  been found to  be immensely responsive to  growth factor 
 13 
 
stimulation and their migration can be stimulated by several molecular signals (Akino et 
al.,  2005).   Once ariving at the site  of injury  MSCs exert  powerful  mediation for the 
progression of wound healing in various ways. 
ENGRAFTMENT AND INTEGRATION INTO REGENERATING TISSUE 
There are two principal theories for how MSCs actualy contribute to the process 
of healing to promote increased tissue repair. Transdiferentiation, the ability of MSCs to 
home to wound sites and integrate as diferentiated cels specific for the regenerating tissue, 
was originaly thought to be a primary mechanism for their role in tissue repair. MSCs 
from  bone  marow  have  been shown to express  keratin folowing their application to 
cutaneous wounds in  mice (Sasaki et al,  2008). These data suggested a contribution to 
wound  healing through  diferentiation into the  keratinocytes  which form the epidermis. 
However, in studies examining the addition of labeled bone marow-derived MSCs into 
mature skin folowing cutaneous injury, MSC incorporation was quite minimal (Badiavas 
et al., 2003). While MSC engraftment can provide some benefits to improve healing, its 
contribution  may  be somewhat  marginal as a result  of  weak cel engraftment, low cel 
retention, and low survival of MSCs at application sites. The high rate of cel mortality 
and low retention is likely caused by an increased level of reactive oxygen species located 
at wound sites, particularly those exhibiting ischemia (Chen et al., 2012). The contribution 
from direct integration of diferentiated MSCs into the wound bed may be less important 
as the  healing  process  progresses, since the engraftment  of  MSCs  wil  decline as the 
regenerated tissue  becomes  more  mature (Chen et al.,  2009b).   Changes in the  wound 
microenvironment likely cause a  decrease in  MSC engraftment as the  healing  process 
advances.  Cytokines and ECM molecules that promote MSC survival and integration into 
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tissue decline during later healing phases (Chen et al., 2009b). Thus the involvement of 
MSC transdiferentiation into new cel types during healing may be initialy important only 
as a way to stabilize the injury (Zou et al., 2012).  
PARACRINE SIGNALING 
MSCs are also able to mediate the repair and regeneration of tissue by recruiting 
inflammatory cels, as  wel as additional stem and  progenitor cels.   Curent evidence 
suggests that  paracrine signaling from  MSCs  plays a  much  more important role than 
transdiferentiation in the beneficial efects of applying MSCs to injuries (Gnecchi et al., 
2008).  Benefits  of  MSC therapies  have  been readily  witnessed even in the absence  of 
noticeably sustained engraftment  of cels  within  damaged tissues.   Conditioned  media 
which contains the  paracrine secretions from  MSCs can  be applied to  wounds to elicit 
similar results as seen with the use of MSCs themselves (Chen et al., 2008). The colective 
MSC secretome acts to trigger and stimulate the recipient’s endogenous repair mechanisms 
at the site  of injury.   Thus, the ability  of  MSCs to  diferentiate  may  provide  negligible 
benefits to  promote  wound  healing.   Conflicting evidence  has  been exhibited  when 
analyzing the  degree  MSC engraftment to tissue  post-injury.   This  may  be  due to cel 
heterogeneity present within MSC populations.  
Regardless of whether engraftment occurs, significant evidence has suggested the 
advantages  of  MSC application to injury  may  be  overwhelmingly  due to  paracrine 
mechanisms.  While dermal fibroblasts normaly provide much of the growth factors in 
cutaneous wound healing, MSCs have been shown to express substantialy more VEGF-
A, erythropoietin, SDF-1α, and EGF (Chen et al., 2008). So instead of MSCs migrating to 
the site of inflammation and undergoing transdiferentiation into fibroblasts, endothelial, 
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inflammatory, or other structuraly significant cels, MSCs may be providing the growth 
factors to promote the migration and proliferation of surounding native cels (Chen et al., 
2008).  Signaling from  MSCs results in  various  processes important in  wound  healing, 
including proliferation,  migration,  genetic expression and celular survival. 
Vascularization and keratinization are also increased in epithelial wounds folowing the 
application of MSCs (Shokrgozar et al., 2012).  
MSCs secrete  VEGF-A, EGF, erythropoietin, and stromal cel-derived factor-1α 
(SDF-1α) (Chen et al., 2012). As mentioned previously, VEGF contributes to angiogenesis 
and helps restore blood perfusion to damaged tissue. EGF binds to its receptor on many 
types of cels to induce cel adhesion, proliferation, and migration. The primary role of 
erythropoietin is the stimulation of red blood cel development, but it can also contribute 
to angiogenesis. SDF-1 is very important for the recruitment of endothelial progenitor cels 
(Zheng et al., 2007) and acts as a potent chemoatractant for T lymphocytes (Bleul et al., 
1996) and MSCs (Nakamura et al., 2013).  In fact, MSCs transfected with a plasmid to 
increase secretion of SDF-1 were able to promote significantly higher rates of migration 
and accelerate wound healing when compared to normal MSCs (Nakamura et al., 2013). 
Numerous other factors may be secreted by MSCs, including substantial amounts of the 
cytokines MIP-1, MIP-2, and MCP-5, which act as chemoatractants for macrophages and 
monocytes. These factors also stimulate macrophage penetration into the tissues at wound 
sites to promote debridement and to clear infections (Chen et al, 2008). 
MSCs  have  been identified  neighboring  newly formed  blood  vessels  but  not 
integrated as a part of the actual vessel wal (Wu et al., 2007b). Accordingly, this suggests 
the MSCs are exerting a paracrine efect to induce angiogenesis rather than diferentiating 
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and incorporating themselves directly into the vasculature structure. MSCs secrete various 
soluble factors, including  SDF-1,  which contribute to the  process  of angiogenesis 
(Goedecke et al., 2011). SDF-1 is also needed to promote the survival of the endothelial 
cels which make up the inner lining of the vasculature, as wel as for the recruitment of 
pericytes, specialized contractile cels that regulate blood flow through capilaries (Zou et 
al., 2012). Folowing cutaneous injury, damage to blood vessels causes a state of ischemia 
due to a lack of adequate oxygen supply to the tissues at the wound site. The resulting 
hypoxia activates the synthesis  of  VEGF, stimulating the formation  of  new  vasculature 
within the  newly synthesized extracelular  matrix (Lokmic et al.,  2006).   Capilary 
reperfusion restoring  oxygen supply to the  wound tissue instigates the formation  of 
oxidative free radicals. Excessive oxidative damage can lead to substantial inflammation 
and the formation of non-healing wounds. MSCs promote the production of antioxidative 
enzymes, such as superoxide dismutase, which catalyzes the destruction of superoxides, 
and  glutathione  peroxidase  which catalyzes the reduction  of  organic  hydroperoxides, 
prompting a reduction in the  oxidative stress and toxicity that  may contribute to the 
pathogenesis  of chronic  wounds (Jeon et al.,  2010).   Detoxification  of reactive  oxygen 
species results in upregulation  of the expression and activity of  VEGF in  wounds, thus 
promoting increased angiogenesis (Bir et al., 2012).  
Fibroblasts are the  predominant cels found in cutaneous injuries and they 
contribute to  healing and scar formation  by inducing  wound contraction, extracelular 
matrix deposition, and tissue remodeling (Smith et al., 2010). These cels are responsible 
for synthesis  of  new colagen and fibrous  proteins to regenerate and strengthen tissues 
folowing injury.  Immediately folowing cutaneous damage, fibroblasts in  neighboring 
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tissues are stimulated to proliferate and to migrate into the wound bed. MSCs can stimulate 
the proliferative phase of cutaneous wound healing by inducing fibroblast migration and 
proliferation to form granulation tissues (Jeon et al., 2010). MSC conditioned media has 
also  been shown to increase colagen and elastin synthesis  by fibroblasts to form the 
extracelular matrix that makes up granulation tissue (Jeon et al., 2010). Furthermore, the 
conditioned  media suppresses the secretion  of  matrix  metaloproteinases (MMPs)  by 
dermal fibroblasts (Jeon et al.,  2010).   These  proteins  degrade extracelular  matrix 
molecules and hydrolyze the type I colagen found in the dermis and mature scars thus 
weakening the wound (Varani et al., 2001). MSCs can diminish the destructive action of 
MMPs, resulting in higher amounts of colagen deposition in the dermis and to improve 
the healing of cutaneous injuries. 
To investigate the  paracrine signaling efects  MSCs  have  on the  migration  of 
dermal fibroblasts, scratch assays  were  performed  utilizing co-cultures  of  MSCs and 
fibroblasts (Walter et al., 2010). The co-cultures were scored in certain areas to remove al 
cels. The scored regions were then monitored to observe the rate of migration back into 
those areas. In these experiments, fibroblast migration was accelerated by the presence of 
MSCs.  A diferent cel migration assay using MSC-conditioned media (which contains 
the soluble secretions from MSCs) was able to confirm MSCs do in fact induce fibroblast 
chemotaxis by the production of soluble factors, since the conditioned media induced the 
same increased rate of fibroblast migration as the cels (Smith et al., 2010). However, there 
can be diferences in the functional abilities of MSCs to signal fibroblast migration. For 
instance, MSCs taken from normal healthy individuals induced a higher rate of fibroblast 
migration in vitro when compared to MSCs taken from an individual experiencing chronic 
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wounds (Rodriguez-Menocal et al.,  2012).   Colectively, this information suggests that 
MSCs  play an extensive role in stimulating the  proliferation and  migration  of the cels 
involved in wound repair. 
IMMUNOMODULATION 
MSCs have also been observed to possess immunomodulatory capabilities. More 
precisely, they  have exhibited immunosuppressive roles  both in vivo and in vitro.   The 
addition  of  MSCs to lymphocytes in a  mixed lymphocyte reaction suppresses  T cel 
proliferation, even in the presence of T cel mitogens (Le Blanc et al., 2002). MSCs can 
suppress  CD4+ and  CD8+  T cel  proliferation  by releasing soluble factors and  by 
modifying  dendritic cels, efector  T-cels, and  natural  kiler cels to adopt a  more anti-
inflammatory  profile (Chen et al.,  2012).   Human leukocyte antigen-G5 (HLA-G5) is 
produced by MSCs and exerts several regulatory actions on immune response, including 
the induction of osmotic lysis of NK and cytotoxic T lymphocytes, increased interferon-γ 
(IFN-γ) secretion, and the promotion of regulatory T cels (Selmani et al., 2007). The IFN-
γ contributes to both the innate and adaptive immunity, primarily through the activation of 
macrophages. Increased macrophage stimulation would likely assist in the debridement of 
cutaneous wounds. T regulatory cels normaly suppress activation of the immune system 
to  prevent autoimmune reactions  or inappropriate recognition  of self-antigens  by the 
lymphocytes.   Understandably, the  primarily immunosuppressive actions  prompted  by 
MSCs can  be  beneficial in  preventing the rejection  of engrafted cels  by suppressing 
possible immune responses. 
MSCs  have  been  used to reduce rejection and complications resulting from 
transplanted tissues and have been utilized to treat autoimmune disorders and conditions 
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such as graft-versus-host disease folowing alogeneic tissue transplantation (Ozaki et al., 
2007). MSCs themselves have been shown to provoke only minimal immunogenicity and 
even those from alogeneic sources have been shown to generate litle to no immunogenic 
response (Chen et al., 2012). The degree of MSC engraftment using alogeneic cels was 
similar to that  of syngeneic cels,  with  neither resulting in  graft rejection (Chen et al., 
2009b).  Therefore, the use of MSCs from sources other than the patient’s bone marow 
shows promise for therapeutic uses without causing immunogenic reactions in hosts. This 
is  promising information for  potential treatments, since injuries  would  often  necessitate 
immediate  MSC application and the employment  of syngeneic  MSCs  would require 
significant time  delays necessary for their isolation and in vitro expansion.   Thus pre-
prepared alogeneic cels could  be readily  utilized  without fear  of rejection  or adverse 
immunogenic responses.   However, there is litle information  on  whether the 
immunosuppressive characteristics  of  MSCs can lead to increased sensitivity to tumor 
formation and opportunistic pathogens. 
MSC DELIVERY 
Yet another reason why MSCs are so actively studied for clinical uses is their ease 
of application. Various delivery methods are being researched to maximize the therapeutic 
potential of MSCs. There are three primary modalities for clinical applications of MSCs: 
intradermaly, topicaly, and systemicaly. Extensive research  has  been  performed to 
investigate usage of both synthetic and non-synthetic biomaterials including fibrin sprays, 
hydrogels, and composite grafts to provide vehicles and scafolds for MSC application. 
One study used a gel developed to mimic the hygroscopic nature of extracelular matrix 
(Lutolf and Hubel 2005). MSCs were seeded and cultured in the gel and then applied to 
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wounds leading to accelerated wound closure. Furthermore, the number of MSCs within 
the wound were about three times greater after one week and ten times more numerous at 
day  10 compared to  wounds treated  with a local injection.   This is  promising since 
difficulties remain to alow celular  homing and  preservation  of transplanted cels in a 
localized area.   Additionaly, recent studies  have  utilized treatments to increase  MSC 
homing.   Exposing  MSCs to certain short  peptides which increase surface integrin 
expression can alow a greater amount of cel adhesion and a higher rate of systemicaly 
infused cels migrating to sites of inflammation (Levy et al., 2015). Alternatively, MSCs 
may  be  modified to express specific ligands through  DNA  or  mRNA transfection to 
promote homing to injury (Sackstein et al., 2008; Levy et al., 2013). Further analysis is 
required to understand optimal dosage, timing, and manner of administration for MSCs to 
ofer beter outcomes in the clinical translation to treatment for individual cases.  
SUMMARY)AND)PROJECT)GOALS)
Curent evidence clearly suggests that cel based therapies, including those which 
utilize  MSCs and  PRP  have an enormous  potential in therapeutic applications and the 
improvement  of  wound  healing.   The capacity for  MSCs and  PRP to accomplish this 
largely results from their ability to secrete  paracrine factors, which enhance  normal 
responses to cutaneous injury. These factors can stimulate the movement of various cels 
that contribute to  healing and recruit them to the  wound site.   Furthermore, the  MSCs 
themselves have been found to be enormously responsive to stimulation by growth factors 
and cytokines. Their ease of atainability and their lack of immunogenic response in hosts 
indicates that they  have  potential for  widespread  use.   The  multiple characteristics  of 
MSCs, including their immunomodulatory, trophic, and  diferentiative  properties, 
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represent incredibly  beneficial and  promising traits  which can  be exploited in clinical 
service. 
One  of the  defining characteristics  of  MSCs is their ability to  diferentiate into 
various cel lineages. The capacity for MSC diferentiation into chondrogenic, adipogenic, 
and  osteogenic cels  wil  be examined in  order to  demonstrate their competence for 
multipotency.   The efects  of  media and culture conditions  on the  morphological, 
phenotypical, and functional  properties  of  MSCs isolated from rat  bone  marow and 
expanded in vitro wil also  be examined.  The curent analysis  wil contribute to 
understanding MSCs and their use in regenerative therapy. The presented here seeks to 
evaluate the efectiveness  of  MSCs and  PRP in  wound  healing, and to  determine the 
optimal dose for MSC use. This work wil examine the healing of surgical incisions in rats 
in response to various MSC dosages. Histological analysis wil also be used to quantitate 
the  degree  of improved wound  healing folowing treatment  with  MSCs,  PRP, and 
ColaTape. Increases in characteristics such as colagen deposition and organization can 
contribute to increased tissue strength that would prevent wound herniation. 
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MATERIALS)
3-isobutyl-1 methylxanthine (Sigma-Aldrich) 
α-MEM (Sigma-Aldrich) 
Alcian Blue (Sigma-Aldrich) 
Alizarin Red S (Sigma-Aldrich) 
Ascorbic acid 2-phosphate (Sigma-Aldrich) 
β-Glycerophosphate (Sigma-Aldrich) 
ColaTape (Zimmer Dental) 
Dexamethasone (Sigma-Aldrich) 
Fetal Bovine Serum (Sigma-Aldrich) 
GlutaMAX (Sigma-Aldrich) 
Indomethacin (Sigma-Aldrich) 
Male Lewis Rats (Charles River Laboratories International Inc. in Wilmington, Mass.) 
Oil Red O (Kodak) 
Penicilin-Streptomycin (Sigma-Aldrich) 
Recombinant human insulin (Sigma-Aldrich) 
RPMI (Sigma-Aldrich) 
Transforming growth factor-β1(PeproTech) 
Trypsin/EDTA (Sigma-Aldrich) 
 )
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METHODS)
ISOLATION)OF)MSCS)
The acquisition and processing of BM-MSCs was performed as in Javazon et al. 
(2001). Two male Lewis rats were euthanized by CO2 inhalation and the femurs and tibias 
were removed from the hind limbs.  The epiphyses of the bones were cut and the bone 
marow was flushed with 10mL of RPMI 1640 media using a 21-gauge needle. The clumps 
were alowed to setle for 5 minutes in a conical tube and al but 0.5mL of the supernatant 
was removed. The cels were centrifuged at 400 x g for 10 minutes at room temperature. 
The pelet was resuspended in 10 mL of complete medium (αMEM containing 20% fetal 
bovine serum (FBS),  2mM  glutaMAX,  100  U/mL  penicilin, and  100 µg/mL 
streptomycin).   A  10µL sample  of the solution  was taken and the  nucleated cels  were 
counted using a hemacytometer folowing treatment with 4% acetic acid. The cels were 
diluted in complete medium to about 1x106 cels/mL and the cels were then added a T75 
culture flask for expansion. 
EXPANSION)OF)MSCS)
The cels (1x107 cels in a T75 cel culture flask) were incubated for 4 days at 37oC 
and  5%  CO2.  The  non-adherent cels  were aspirated  of and  10mL  of fresh  media  was 
added. The cels were fed every 3-4 days until the cels reached 80% confluency. The 
cels were washed with PBS and trypsinized using a treatment of a 3mL solution of 1X 
trypsin and EDTA (0.25% trypsin and 1.0mM EDTA) for 7 minutes at 37ᴼC. The cels 
were dislodged by tapping the flask and the reaction was ended by the addition of 30mL 
of complete medium. The cels were then split into two flasks. The expansion of MSCs 
 24 
 
was continued until the third passage. The cels were then counted using a hemacytometer, 
centrifuged for 5 minutes at 600 x g, and resuspended in complete media containing 10% 
DMSO to achieve a concentration  of  1x106 cels/mL.   The  MSCs  were then  placed in 
cryovials, frozen slowly for 24 hours at -80°C, and then stored in liquid nitrogen. 
OSTEOGENIC)DIFFERENTIATION)
 The protocol for al diferentiation assays were adapted from procedure in Chen et 
al. (2009a).  In order to evaluate osteogenic potential, 2x105 MSCs in the third passage 
were seeded into a 6 wel plate. The cultures were incubated at 37ᴼC in 5% atmospheric 
CO2 and alowed to become confluent. Half of the wels were maintained with complete 
media  while the remaining  were  maintained  with  osteogenic  medium (200µM ascorbic 
acid  2-phosphate,  100nM  dexamethasone,  10mM β-glycerophosphate,  10%  FBS,  2mM 
glutaMAX, and 1% penicilin/streptomycin in DMEM high glucose) for three weeks (Chen 
et al., 2009a). Media was aspirated of the cels and fresh media was added every 2-3 days.  
 To identify the  presence or absence of  osteogenic  diferentiation, the cels  were 
washed  with  PBS and then fixed  with a  10% formalin solution for  one  hour at room 
temperature. Formalin  was removed and the cels  were  washed  with  distiled  water. 
Alizarin Red S (2%) was dissolved in distiled water. The pH was adjusted to 4.2 using 
0.1% NH4OH and the solution was filtered. The wash solution was aspirated from the cels, 
the botom of the wel was covered with 2% Alizarin Red S stain (pH 4.2) and alowed to 
incubate at room temperature in the dark for 45 minutes. The cels were washed four times 
with 1mL of distiled water and PBS was added to each wel. The cels were visualized 
using an inverted phase contrast microscope. 
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ADIPOGENIC)DIFFERENTIATION)
To evaluate adipogenic potential, 2x105 MSCs in the third passage were added to each 
wel of a 6 wel plate. The cultures were incubated at 37ᴼC in 5% atmospheric CO2 for 48 
hours with complete media until they reached confluence. To induce diferentiation, the 
cels in three  of the  wels were  maintained in adipogenic  media containing 1µM 
dexamethasone, 500µg/mL insulin,  1µM indomethacin,  500µM  3-isobutyl-1 
methylxanthine (IBMX), 10% FBS, 2mM glutaMAX, and 1% penicilin/streptomycin in 
DMEM high glucose for three weeks (Chen et al., 2009a). The remaining 3 wels were 
maintained with complete media. The media was aspirated and replaced every 2-3 days.  
The cels were stained with Oil Red O to detect lipogenesis. Cels were taken from the 
incubator and washed with PBS. The solution was aspirated of and about 1mL of neutral 
bufered formalin (10%) was added and alowed to incubate at room temperature for 30 
minutes.  A 0.3% stock solution was made by dissolving 300mg Oil Red O in 100 mL 
isopropanol. The staining solution was prepared by diluting 3 parts of the stock solution 
with 2 parts distiled water and filtering with a syringe filter. The fixation solution was 
aspirated of the cels which were subsequently washed with distiled water. About 1mL 
of 60% isopropanol was added and alowed to incubate for 5 minutes before being aspirated 
of. Enough Oil Red O staining solution was added to cover the cels (about 1mL) and 
incubated for 15 minutes. The stain was removed and the cels were washed with water 
until wash became clear. PBS was added to cover the cels and images were taken using 
an inverted phase contrast microscope. 
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CHONDROGENIC)DIFFERENTIATION)
 In order to evaluate chondrogenic potential, 2x105 MSCs in the third passage were 
added to each  wel  of a 6 wel  plate.   The cultures  were incubated at  37ᴼC in  5% 
atmospheric  CO2 for  48  hours  with complete  media  until the cels reached confluence. 
Chondrogenic  media (1% insulin-transferin-selenium (ITS), 50µg/mL ascorbic acid, 
100nM dexamethasone,  10ng/mL  TGF-β1,  2mM glutaMAX, and  1% 
penicilin/streptomycin in DMEM high glucose) was then used to maintain half of the wels 
while complete media was used for the remaining wels (Chen et al., 2009a). Media was 
aspirated of the cels and fresh media was added every 2-3 days for 3 weeks.  
The wels were then stained with 0.01% Alcian Blue to visualize the formation of 
cartilage and colagen secretion indicative  of chondrocyte formation.   The cels  were 
washed  with  PBS and then fixed  with a 10% formalin solution for  one  hour at room 
temperature. The formalin was removed and the cels were washed twice with distiled 
water. The staining solution was prepared by dissolving about 10mg of Alcian Blue 8 GX 
dye in a 60:40 solution of ethanol and acetic acid. Enough stain was added to the wels in 
order to cover the cels and alowed to incubate overnight in the dark at room temperature. 
The stain was aspirate and 1mL of a destaining solution consisting of 120mL ethanol and 
80mL acetic acid was added and incubated for 20 minutes. The destaining solution was 
aspirated of and PBS was added to cover the cels which were then visualized and imaged 
with an inverted phase contrast microscope. 
PLATELET4RICH)PLASMA)PREPARATION)
 The  protocol for colection  of  PRP  was  modified from the  work  performed  by 
Maekawa et al. (2003). Blood was colected from male Lewis rats via a heart puncture 
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using a 21-gauge needle and a 10mL syringe containing 1/10 volume of citrate dextrose. 
The blood was centrifuged at room temperature in a conical tube for 10 minutes at 200 x 
g. The plasma layer was removed and centrifuged at 700 x g for 10 minutes. The upper 
(platelet-poor) layer was removed and stored at -20ᴼC leaving about 1 mL portion with the 
platelet pelet. The pelet was resuspended folowing the addition of 5% DMSO. The PRP 
was frozen slowly by gradualy decreasing temperature to -80ᴼC. Subsequently, the frozen 
pelets were stored in liquid nitrogen. In order to thaw PRP for later use, the frozen pelet 
was quickly melted by adding it to 1 mL warm plasma and mixed.  The PRP was then 
centrifuged at 700 x g for 10 minutes at 4ᴼC. The plasma is aspirated of and the remaining 
pelet is resuspended in plasma.  
SURGERIES)
A wound healing analysis was performed using male Lewis rats. Isoflourane (3-
5%) anesthesia  was induced and the abdomen  of  was shaved and sterilized  by  washing 
with 70% isopropanol. An abdominal skin incision was made from the xiphoid to pubis 
region. The skin flaps were puled back and a ful-thickness midline incision of 60mm in 
length starting at the xiphoid process and extending inferiorly was made in the abdominal 
wal. The incision was closed using about 15 running Vicryl sutures. Each corner of a 6x1 
cm strip of ColaTape was fixed over the wound using sutures to the rectus sheath and a 
suspension of varying amounts of MSCs (2.5x104, 5x104, 1x105, 2.5x105, 5x105, and 1x106 
cels) in 0.5 mL platelet-rich plasma were applied to the ColaTape. The skin was repaired 
using  5-0  Vicryl subcuticular sutures.  A control  group received  no treatment and  was 
repaired with only sutures. One group also received a sham treatment of ColaTape and 
0.5mL PRP, but no MSCs. The rats were monitored and alowed to recover for 4 weeks in 
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normal  bedding/conditions and then sacrificed via  heart  puncture  under isoflourane 
anesthesia. For sample colection, incisions were made horizontaly across the abdominal 
wal above and below the area of tissue to be colected. A metal plate was inserted under 
the musculature and a metal stamp was used to cut out precise shapes from the tissue for 
various analyses as shown in Figure 1. One of the wound samples were taken for trichrome 
staining and histological analysis. 
HISTOLOGICAL)SCORING)FOR)WOUND)ANALYSIS)
Midline sections consisting of the healed incision site were parafin embedded and 
cross-sections  were fixed  on slides.   The samples  were then subjected to Masson’s 
trichrome staining staining as performed in Hefner et al. (2012). Images of the wound site 
were taken  using  40x  magnification.   The images  of the trichrome stained slides  were 
assessed similar to the procedure by Stanwix et al. (2011), based on the grading scale in 
Figure  2 in  order to  determine  how treatment  with  MSCs and  PRP afected the  wound 
healing  process. The images  were randomized and the  degree  of colagen abundance, 
colagen  organization, and  myocyte regeneration  was  determined and the resulting  data 
was averaged. Criteria explaining the how scores for specific tissue characteristics were 
given is explained in Figure 2. 
DATA)ANALYSIS)
Diference of histological scores between groups receiving varying treatments was 
analyzed by performing a one-way ANOVA using Microsoft Ofice Excel 2016. Mann-
Whitney testing was performed using IBM SPSS Statistics 20 to provide pairwise analysis 
between groups. Statistical significance was accepted with a p value of less than 0.05. 
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 Figure 1: Sample colection diagram. This ilustration depicts the wound location 
and sample colection sites from the ventral portion of the male Lewis rats utilized in this 
study. Al wounded tissues received a 60mm ful-thickness incision through the abdominal 
musculature extending from the xiphoid process to the pubis (dashed red line). The samples 
colored yelow and green were sent to other laboratories. The yelow strips were used to 
test  wound  breaking strength  using a tensiometer.   The  green samples  were  used to 
determine composition of type I and type II colagen at the wound site. The blue strip in 
the  middle  was  used for  Masson’s  Trichrome staining to  determine  histological 
characteristics. 
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Figure 2: Histological scoring criteria. These standards were utilized to determine and 
quantify tissue characteristics and morphology. Samples which exhibited tightly packed 
and unidirectional colagen fibrils with limited celular infiltration were given a score of 3 
while those which did not exhibit these traits received a score of 0.  Samples which 
displayed some of the characteristics were given a 1 or 2. Colagen abundance was semi-
quantitatively determined through subjective analysis and given a score from 0 to 3 based 
on perceived colagen amount. Myocyte regeneration was based on the presence of smal 
muscle packets forming at the edges of the incision site.  The degree was of muscle 
regeneration was visualy determined and given a score from 0 to 3.
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RESULTS)
Previous studies have shown that bone marow MSC cels can diferentiate into a 
variety  of  mesenchymal-derived cell types (Azouna et al.,  2012;  Wu et al.,  2007b; 
Goedecke et al., 2011). Thus, the rat BM-MSC cels grown in culture for the curent study 
were investigated for their in vitro osteogenic, adipogenic, and chondrogenic 
diferentiation to determine their inherent multipotentency. Cels seeded into a 6-wel plate 
were alowed to reach confluence while grown with complete media. Diferentiation media 
was then added to the test the cels (3 weeks in osteogenic and chondrogenic medium; 2 
weeks in adipogenic medium), while control cels were maintained with complete media 
for the same amount of time. Cels undergoing induced diferentiation and their respective 
controls were performed in triplicate (N=3). 
The occurence of calcified matrix mineralization is indicative for the development 
of osteocytes which act to form bone tissue (Vater et al., 2010).  Mineralization can be 
identified early in culture by the accumulation of calcium phosphate crystals which can be 
detected by staining with Alizarin Red S (Birmingham et al., 2012). Positive staining was 
indicated  by areas  of reddish-brown staining in cultures treated  with  osteogenic  media, 
suggesting the presence of extracelular calcium deposits (Figure 3B). This indicates that 
treated cels may have diferentiated into osteoblasts. Cels maintained in normal growth 
media served as a control and were negative for Alizarin Red S staining (Figure 3A). 
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Figure 3: Osteogenic Diferentiation. BM-MSC cels cultured for 3 weeks in the absence 
(A) or presence (B) of osteogenic medium. Both cultures were stained with 2% Alizarin 
Red S to indicate the presence of calcium deposition. Positive staining, seen as the pale 
reddish-brown areas in (B), suggests the formation of calcified extracelular matrix. 
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Oil Red O is a stain specific for neutral triglycerides and lipids (Vater et al., 2010). 
Cultures treated with adipogenic media for 2 weeks showed positive staining with Oil Red 
O as indicated by accumulations of intracelular lipid vacuoles staining red (Figure 4B). 
This suggests MSCs may have diferentiated into an adipocyte lineage. Cels maintained 
in  normal  growth  media served as a control and  were  negative for  Oil  Red  O staining 
(Figure 4A). 
Chondrogenic  media induces the cels to  undergo  diferentiation and  produce 
extracelular matrix composed of cartilage-specific molecules including type I colagen 
and aggrecan (Solchaga et al.,  2011).  Alcian  Blue,  which is specific for al types  of 
colagen and glycosaminoglycans (Vater et al., 2010) stained the deposits of colagen and 
extracelular matrix in the cel culture to suggest the generation of chondroblasts (Figure 
5B). Cels maintained in normal growth media served as a control and were negative for 
Alcian Blue staining (Figure 5A). 
Since the application  of  MSCs to cutaneous  wounds  has shown to  provide 
therapeutic benefit and accelerate healing (Chen et al., 2012; Nakamura et al., 2013; Jeon 
et al.,  2010;  Liu et al.,  2013), an investigation  was also performed to examine the 
efectiveness  of topical applications  of BM-MSC cels and to  determine the  optimal 
concentration of alogeneic MSCs in the treatment of abdominal wal incisional wounds. 
A histological analysis was performed using a rat model to determine changes in wound 
healing characteristics folowing varying treatments to promote tissue regeneration after 
invasive laparotomy surgeries.  MSCs  were suspended in  PRP at six diferent 
concentrations (2.5x104, 5x104, 1x105, 2.5x105, 5x105 and 1x106 cels per 0.5mL of PRP)  
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Figure 4: Adipogenic Diferentiation.  BM-MSC cels grown for 2 weeks in the absence 
(A) or presence (B) of adipogenic medium. Both cultures were treated with 0.2% Oil Red 
O to stain for intracelular lipid  droplets.  The red staining  of cels in (B) indicates the 
occurence of lipogenesis. 
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Figure  5: Chondrogenic Diferentiation.  BM-MSC cels cultured for  3  weeks in the 
absence (A) or presence (B) of chondrogenic medium. Both cultures were stained with 
0.01% Alcian Blue to determine the presence of colagen deposition. 
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and the suspensions  were applied to  ColaTape fixed  over a ful-thickness abdominal 
incision which was closed with suture repair. A control group received only suture repair 
and a sham group had ColaTape and PRP applied over the sutures. The abdominal wal 
tissue samples from the wound site  were  harvested at 4  weeks of  healing,  parafin 
embedded, sectioned, and trichrome stained (performed  by the  St.  Elizabeth  Hospital 
Pathology  Department) to  demonstrate colagen  deposition and tissue  morphology. The 
trichrome stained tissue sections were also used for semi-quantitative scoring of colagen 
fiber abundance after 4 weeks of healing. Scores from 0 to 3 were subjectively given to 
each  of the samples for three criteria: colagen abundance, colagen  organization, and 
myocyte regeneration. Criteria for deciding scores are detailed in Figure 2.  
Representative images of the abdominal wal tissue samples for the control group, 
sham  group, and the treated groups receiving the lowest (2.5x104) and  highest (1x106) 
number of cels are shown in Figure 6. The presence of colagen fibers was indicated by 
bright blue staining and muscle fibers are stained red. The stained tissue samples showed 
a noticeable increase in both colagen amount and organization for the groups receiving 
MSC treatment when compared to wounds with no added MSCs. Animals treated with the 
highest number of MSCs (1x106) exhibited numerous colagen fibers which were largely 
aranged unidirectionally and densely packed against one-another, and displayed limited 
celularity among the colagen fibers. Control individuals (Figure 6B) had litle colagen 
deposited at the wound site while the samples from the sham group (Figure 6C) had slightly 
more colagen abundance. The control tissues also had litle to no myocyte regeneration 
(Figure 6B). Myocyte regeneration was indicated by the formation of smal colections of 
new muscle tissue at the edges of the incision. Groups receiving MSC therapy (Figures  
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Figure 6: Wound Analysis of the Abdominal Fascia.  Representative  Masson’s 
Trichome stained images of rat abdominal wal musculature folowing 4 weeks of varying 
treatments for fascial wound healing. Colagen appears as a vivid blue and muscle cels 
are stained pink/red. These images were used to determine wound characteristics including 
colagen abundance, colagen organization, and myocyte regeneration. Al images were 
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taken at  40x  magnification. (A) Unwounded abdominal  wal tissue,  with the image 
centered at the linea alba; (B) Wounded tissue (Control) which received only suture repair 
and  no additional treatment; (C)  Wounded tissue receiving 0.5mL  PRP (Sham) applied 
over a band of 6x1 cm ColaTape; (D and E) Wounded abdominal tissue which received 
treatment with varying amounts of MSCs in a PRP suspension over ColaTape; (D) Tissue 
treated with 2.5x104 MSCs; (E) Tissue treated with 1x106 MSCs. 
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6D and 6E) exhibited increased muscle regeneration and were rich in colagen that was 
highly organized when compared to the control (Figure 6B).  
Analysis of colagen abundance data showed that there was statisticaly significant 
diference between al groups receiving MSC therapy and the control (p<0.01) (Figure 7). 
There was a noticeable increase in colagen when treating the wound with only ColaTape 
and PRP (Sham group) when compared to the control group which received only suture 
repair. Furthermore, groups which also received MSC treatment generaly had an increase 
in colagen  deposition  with increasing  dosages  of  MSCs.  However,  only the  groups 
receiving 1x105 and 1x106 MSCs were significantly higher than the sham group (p<0.05).  
There was a dip in the colagen abundance with groups receiving 2.5x105 and 5x105 cels. 
Furthermore, the group receiving the most MSCs (1x106) had more colagen deposition 
than the group receiving the least amount of cels (2.5x104 MSCs). 
A similar trend was seen in colagen  organization.   The  groups receiving  MSC 
therapy generaly had a higher degree of organization when compared to the control. There 
was also a mild decrease in organization for the groups receiving 2.5x105 and 5x105 cels. 
There was a statisticaly significant increase in colagen organization between the control 
and the groups receiving 1x105 and 1x106 MSCs (p<0.05). Only the group treated with 
1x106 cels was significantly higher than the sham group (p<0.05).  
 The sham group and the groups receiving MSC therapy exhibited much higher new 
muscle growth when compared to the control (Figure 9) and there was on average about an 
8-fold increase in the sham and  MSC-treated  groups (p<0.05).  However, there was  no 
noticeable trend among the groups which received MSC therapy and were found to not be 
statisticaly diferent from one another or the sham group (p>0.05). 
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Figure 7: Colagen Abundance at MSC Treated Wounds. Histological determination 
of colagen abundance in wounds receiving varying MSC dosages. Abdominal wal tissue 
sections were stained  with  Masson’s  Trichrome to  visualize colagen deposition at the 
wound site. Scores ranging from 0 to 3 were given to each sample by an observer to semi-
quantitatively determine the amount of colagen fibers. Data represent the mean ± standard 
eror of the scores for each group. Control groups received only suture repair and the sham 
group also had PRP and ColaTape but no MSCs applied to the wound. MSC treatment 
was  performed  using  diferent concentrations  of  MSCs in a  PRP suspension  with 
ColaTape. The groups receiving MSC and sham treatment were statisticaly diferent from 
the control when analyzed by one-way ANOVA (p=0.0019). Groups receiving 1x105 and 
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1x106 MSCs had elevated colagen deposition when compared to the sham group (p<0.05). 
N=14 for groups receiving 2.5x104, 2.5x105, and 5x105 cels and N=7 for al other groups. 
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Figure 8: Colagen Organization at MSC Treated Wounds. Histological determination 
of colagen fiber organization in wounds receiving varying MSC dosages. Abdominal wal 
tissue sections were stained with Masson’s Trichrome to visualize colagen fiber deposition 
within the wounded tissue. Scores ranging from 0 to 3 were given to each sample by an 
observer to quantitate the degree of colagen organization at the wound site, based on the 
degree to  which colagen fibers  were tightly  packed and  organized into paralel fiber 
bundles, with limited celular infiltration.  Data represent the mean ± standard eror of the 
scores for each group.  Control groups received only suture repair and sham groups had 
PRP and ColaTape but no MSCs applied to the wound. MSC treatment was performed 
using diferent concentrations of MSCs in a PRP suspension with ColaTape. The group 
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receiving 1x105 MSCs had increased organization when compared to the control (p<0.05) 
and the group receiving 1x106 MSCs had higher organization than both the control and 
sham groups (p<0.05). N=14 for groups receiving 2.5x104, 2.5x105, and 5x105 cels and 
N=7 for al other groups. 
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Figure  9:  Myocyte  Regeneration at MSC  Treated  Wounds.  Histological 
determinations  of  myocyte regeneration in  wounds receiving  varying  MSC  dosages. 
Abdominal wal tissue sections were stained with Masson’s Trichrome to visualize muscle 
regeneration at the wound site. Myocyte regeneration is evidenced by the presence of smal 
packets of red-staining cels at the margins of the incision site.Scores ranging from 0 to 3 
were given to each sample by an observer as a measure of new muscle growth at the wound 
edges.  Data represent the  mean ± standard eror of the scores for each  group.  Control 
groups received only suture repair and the sham group also had PRP and ColaTape but no 
MSCs applied to the wound. MSC treatment was performed using diferent concentrations 
of  MSCs in a  PRP suspension  with  ColaTape.  The  groups receiving  MSC and sham 
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treatment  had increased  muscle regeneration  when compared to the control (p<  0.05). 
There were no diferences among the groups receiving MSC treatment and the sham group. 
N=14 for  groups receiving 2.5x104 and  2.5x105 and  5x105 cels and  N=7 for al  other 
groups. 
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DISCUSSION)
Experiments  using rat and mouse models  have  been  valuable in assessing the 
therapeutic potential of MSCs to promote tissue regeneration folowing injury (McFarlin 
et al., 2006; Wu et al., 2007b). The eficacy of these bone marow-derived cels has been 
further demonstrated in the curent study by determining their efect on abdominal fascia 
healing folowing a surgical incision. The purpose of this study was to determine efective 
concentrations of bone marow-derived MSCs for improved wound healing. Specificaly, 
the regeneration of tissue in the abdominal wal folowing surgical incisions was of interest. 
Herniation  of incisional  wounds remains a significant  problem  during surgery recovery 
with occurence in about 10% of individuals receiving laparotomy procedures (Bucknal 
et al., 1982). With improved healing and strength of the fascia and abdominal tissue, the 
occurence of incisional hernia post-surgery would decrease. The efectiveness of MSC 
application is dependent upon the number of cels applied to the incision (Falanga et al., 
2007). Previous work from this laboratory has established the beneficial efects of using a 
dosage of 1x106 cels in addition to PRP and ColaTape to treat incisional wounds (Hefner 
et al., 2012). The combination of supplemental biological and celular additives such as 
PRP and  ColaTape may synergisticaly  magnify the therapeutic advantage  of  MSC 
therapy.  We  hypothesized that lower  dosages of  MSCs, in combination  with  PRP and 
ColaTape treatment, may provide similar benefits for enhancing fascial healing as seen in 
previous studies using higher doses of MSCs (Hefner et al., 2012). This study examined 
this hypothesis on abdominal wound healing in rats by looking for increases in colagen 
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organization, deposition, and  myocyte regeneration folowing treatments  with  various 
dosages of MSCs. 
Previous studies have demonstrated that MSCs can diferentiate into a variety of 
mesenchymal-derived cel types (Azouna et al., 2012; Wu et al., 2007b; Goedecke et al., 
2011).  In the present study, it was found that the cels isolated from bone marow and 
expanded in culture likely held a  diferentiative  property consistent  with  mesenchymal 
stem cels by indicating an ability to develop into osteocyte, adipocyte, and chondrocyte 
cel lineages. Applying those BM-MSCs to incision sites resulted in augmented colagen 
deposition and organization after 4 weeks of healing.  Wounds receiving 1x106 cels had 
the highest degree of colagen abundance and organization while the individuals receiving 
only suture repair had the lowest. A significant diference in myocyte regeneration was 
not  observed  with an increasing  dosage  of  MSCs;  however, each  group, including that 
which received  only  PRP and  ColaTape, had increased  new  muscle  growth  when 
compared to rats which received only suture repair. Increasing the number of data points 
by performing surgeries on more subjects or by including histological scores assigned to 
the samples by several individuals could reveal statistical significance between the various 
groups for characteristics such as colagen organization and myocyte regeneration since 
trends in the curent  data suggest certain  diferences  despite the lack  of statistical 
significance. 
Whether from bone marow or adipose tissue MSCs obtained from diferent sources 
maintain similar phenotypic properties (Li et al., 2013; Lee et al., 2004). However, slight 
diferences at the RNA and protein level have been observed, alowing the ability to trace 
the cels back to their tissue of origin (Lee et al., 2004). Therefore, a specific stem cel 
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source may be more desirable for treating a particular disease or a certain target tissue. No 
discernable diferences resulting from MSC treatment of cutaneous wounds utilizing cels 
from varying sources have been identified, and therefore colection of MSCs from a readily 
available source, such as bone marow, can be useful for studying their efects on healing 
(Liu et al., 2013).  
Successful induction  of cel  diferentiation into  various cel types (adipocytes, 
osteocytes, and chondrocytes) demonstrates the stem nature of the cels isolated from bone 
marrow aspirates and subsequently expanded in culture (Dominici et al., 2006). The ability 
to diferentiate into various tissues can also indicate the type of stem cel, since most are 
limited in which terminal lineages they may develop into (Seita and Weissman 2010). Thus 
demonstrating the  diferentiation  of the cels isolated from the femoral and tibial  bone 
marow of the rats into adipogenic, osteogenic, and chondrogenic lineages, indicates that 
the cels utilized in the treatment of incisional wounds contain MSCs. Because the cels in 
culture appeared to diferentiate, it disproves the notion that other plastic-adherent stromal 
cels or hematopoietic stem cels from the marow are prevalent in the ex vivo culture as 
these other cel types cannot diferentiate into mature, mesenchymal-derived cels (Seita 
and Weissman 2010). However, since we did not culture the cels from a pure population 
of stem cels and the cel cultures may stil contain  other stromal cels  having similar 
morphology, the cels should be identified as mesenchymal stromal cels which include a 
stem population, as demonstrated by celular diferentiation. 
The ability  of  MSCs to  diferentiate into discrete cel lineages provides a 
tremendous opportunity for treating numerous types of diseases and injuries. MSCs have 
proven to  be a  valuable for the treatment of damaged  or  malformed bone and cartilage 
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(Porada and  Almeida-Porada,  2010).  In addition,  MSCs  have  been shown to  produce 
fibroblasts,  keratinocytes, functional skeletal  muscle cels, neurons, cardiomyocytes, 
endothelium, and hepatocytes among other cel types (Parada and Almeida-Porada, 2010). 
With such an extensive diferentiative repertoire, MSCs may be capable of integrating into 
a number of diferent tissues and organs and producing new cels. 
Histological analysis suggested the MSCs that were expanded in culture were able 
to diferentiate into more mature cel types, and thus may be capable of becoming bone, 
fat, or cartilage cels.   The  media  used for culture was supplemented  with additives to 
promote specific diferentiation of the MSCs into a mature cel type. Previous studies have 
shown that the addition of glucocorticoids, such as dexamethasone, to the culture media 
can stimulate the in vitro diferentiation of multiple cel lineages, including bone, fat, and 
cartilage cels due to its ability to induce certain transcriptional activities (Derfoul et al., 
2006; Vater et al., 2011). Thus dexamethasone was added to each of the diferentiation 
media used in this study. Osteogenic and chondrogenic diferentiation media also included 
ascorbic acid since it  has a  mitogenic efect  on the cels and increases colagen 
hydroxylation (Choi et al., 2008). In addition, β-glycerophosphate was added to osteogenic 
media to provide a source  of inorganic  phosphate,  which is  needed to  produce the 
mineralized extracelular  matrix  of bone tissue (Vater et al.,  2011).  The chondrogenic 
media contains transforming growth factor β to promote glycosaminoglycan and type I 
colagen accumulation (Vater et al.,  2011). Adipogenic  media includes insulin,  which 
increases triglyceride accumulation, as wel as the additives 3-isobutyl-1-methylxanthine 
and indomethacin to  prevent  osteogenesis and to  promote celular commitment to the 
adipogenic lineage via transcriptional alterations (Vater et al., 2011).  
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Ultimately, the apparent diferentiation  of BM-MSCs  was  observed folowing 
treatment using media with these additives. Cultures of bone marow-derived cels showed 
positive staining  with Alizarin  Red  S,  Oil  Red  O, or Alcian  Blue after treatment  with 
osteogenic, adipogenic, or chondrogenic diferentiation media. These findings suggest that 
immature cels were capable of diferentiation into more mature cel types. Thus the cels 
taken from rat bone marow can now be tentatively identified as MSCs. However, since 
the cels were not sorted based on their phenotypic characteristics, it is likely that there are 
some additional types of cels, including mesenchymal stromal cels, which may be found 
in our cultures. A large proportion of the cels demonstrated the ability to diferentiate, 
indicating that our bone marow-derived cel population has a high prevalence of MSCs 
and the cels are appropriate for the  purposes  of this studying the ability  of  MSCs to 
promote wound healing. 
Eforts are underway to optimize the delivery methods necessary to preserve and 
enhance the therapeutic benefits of MSC usage in wound therapy.  Generaly speaking, 
most therapeutic applications of MSCs dictate that exogenous cels are expanded in vitro 
prior to administration either systemicaly  via the circulation  or through direct/topical 
application (Chen et al., 2012). Understandably, topical application of MSCs was chosen 
for this study since it  provides the most  direct and  practical  modality for  delivery and 
represents a simple methodology that may be applied to a clinical procedure. 
The  benefits  of  MSC application have  been evident  within the first few  days 
folowing injury (Wu et al., 2007b; Chen et al., 2008), suggesting the cels largely afect 
the early stages  of  healing,  which is  defined  by a  high  degree  of cel recruitment and 
angiogenesis. In the study by Wu et al. (2007b), BM-MSCs were applied via intradermal 
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injections surounding excisional dermal wounds in the dorsal skin of Balb/C mice. The 
number  of  MSCs remaining at the  wound  was  drasticaly reduced  within the first two 
weeks after application. About 10% were engrafted into the wound tissue after one week 
and only about 3% remained after two weeks. With progression of the healing process, 
cytokines and extracelular matrix molecules which are advantageous for MSC survival are 
likely to decrease and thereby causing MSC engraftment to decline (Chen et al., 2009b; 
Von Bahr et al., 2012). Accordingly, early administration of MSCs may be beneficial to 
ataining maximum regenerative capabilities. To adhere to this logic, the application of 
MSCs to incisions in our study was performed directly after injury.  
Diverse types  of synthetic and  nonsynthetic biomaterials are commonly  used in 
atempts to increase the functional benefits of the MSC therapy, based upon the type of 
injury needing treatment (Falanga et al., 2007; Lutolf and Hubel 2005). As performed in 
the curent investigation, applying a scafold such as a colagen band (ColaTape) on top 
of the incision may provide benefits for increasing engraftment and preserving the cels at 
the  wound folowing application  of the cel suspension at the abdominal surgical site 
(Marie et al., 2010). The ColaTape may act as an external niche for the MSCs to remain 
at the wound site, so that they may provide a more sustained paracrine influence on the 
local environment.  Additionaly, PRP increases  MSC  proliferation through platelet 
secretion of specific growth factors such as PDGF and TGF-β (Goedecke et al., 2011). PRP 
may also provide an aray of other factors which also act synergisticaly to those secreted 
by MSCs to direct cel processes involved in tissue regeneration (Goedecke et al., 2011). 
Increases in colagen abundance, organization, and myocyte regeneration seen when using 
PRP and ColaTape alone indicate the potential to provide beneficial therapy. Since the 
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MSCs were applied along with PRP to the abdominal fascia, the therapeutic benefit of the 
cel suspension may be amplified. 
Previous work in this laboratory have shown that using MSC, PRP, and ColaTape 
treatment results in a tremendous increase in the tensile strength  of the abdominal  wal 
(Hefner et al., 2012). A study by McFarlin et al. (2006) similarly examined the use of BM-
MSC treatment to promote fascial repair in rats. The investigators made a ful thickness 
incision in the abdominal fascia  of  Sprague-Dawley rats and applied  6x106 BM-MSCs 
through local intradermal injections immediately after closing the  wound.   The  wound 
breaking strength  of the abdominal tissue folowing MSC treatment increased two- to 
threefold when compared to untreated individuals at one and two weeks folowing surgery. 
Additionaly, the abdominal fascia  had increased colagen  deposition folowing  MSC 
treatment at both the 7 and 14-day time points (wound tissue was homogenized and total 
soluble colagen (types I-IV) was measured colorimetricaly using a colagen assay). An 
increase in the  organization  of colagen fibers  was also  noted in  histological analysis. 
Based on the histomorphological characteristics of the wound tissue, it was concluded that 
there was a swift completion of the early phase of tissue repair involving inflammation and 
granulation tissue production. These outcomes are consistent with the results of the curent 
investigation.   The improvement of wound tensile strength can be atributed to various 
factors including new colagen synthesis, matrix deposition, and celular migration. Thus 
an increase in the regeneration of fascial tissue and increased strength can be best ascribed 
to an increased amount  of colagen in the  wound.  In the  present study, the enhanced 
generation of colagen with certain MSC dosages, including 1x106, may directly translate 
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to improved tissue strength during and after healing.  This improvement could possibly 
reduce the incidence of incisional herniation in patients receiving invasive surgeries. 
While increased colagen was noted in most of the animals receiving high MSC 
concentrations, there  was a  decrease in colagen  organization and abundance in the 
individuals receiving  2.5x105 and  5x105 cels.   This is curious, since a relatively linear 
increase would be expected with increasing MSC concentration up to a maximaly efective 
dosage. At that point, there would likely be a plateau in these colagen characteristics and 
higher doses would result in marginal increases in the promotion of healing mechanisms 
and characteristics.   Thus the therapeutic  benefit  would  no longer  be augmented by 
administering increasing amounts of MSCs. However, using high concentrations of these 
cels may even have an inhibitory efect on  healing because  of their potent anti-
inflammatory and immunosuppressive properties, thereby reducing the recruitment of cels 
such as fibroblasts,  keratinocytes, and endothelial cels, which are necessary for tissue 
regeneration and remodeling (Aggarwal et al., 2015; Selmani et al., 2008). In this instance, 
the early stages  of  healing  may  be  highly truncated,  with a significantly shorter 
inflammatory phase which is normaly required to induce migration of native cels to the 
wound microenvironment.  Dosage has been shown to be important in other studies. For 
instance, one investigation using a fibrin spray with MSCs to treat chronic wounds showed 
that  dosages  of at least  1x106 per cm2 of  wound  were  necessary to induce therapeutic 
benefits in db/db mice. Doses larger than 2x106 resulted in similar outcomes, signifying a 
diminishing return from the addition  of increasing cel concentrations (Falanga et al., 
2007). Another investigation  using a rat  brain injury  model established that there is a 
responsive plateau, where the addition of increased numbers of MSCs could not further 
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enhance a beneficial efect (Wu et al., 2007a). The data from our study indicates that doses 
of as litle as 2.5x104 MSCs can provide favorable influence on healing. 
In the early stages  of  healing, inflammatory cels  provide  growth factors  which 
induce the migration and proliferation of fibroblasts at the wound where they subsequently 
begin to synthesize matrix components including type I and type II colagen (Jeon et al., 
2010). The paracrine activity of MSCs complements endogenously produced factors and 
cytokines produced during wound healing that are involved in celular processes such as 
proliferation, signaling, extracelular  matrix synthesis, and angiogenesis (Chen et al., 
2014).   For instance, factors secreted  by  MSCs  have  been shown to induce colagen 
synthesis from dermal fibroblasts in vitro (Kim et al., 2007). Typicaly type II colagen is 
produced  quickly after injury (Lokmic et al.,  2006).  Increased  prevalence  of immature 
type II colagen rather than the stronger type I colagen in the abdominal wal results in 
higher rates of herniation (Henriksen et al., 2010). Tissues with more abundant type II 
colagen  have thinner fibers  with  decreased  biomechanical strength (Henriksen et al., 
2010). As healing progresses, type II colagen is degraded by MMPs and replaced by the 
more robust type I colagen to provide a stronger and more cohesive tissue (Lokmic et al., 
2006). In the studies  by  Lokmic et al. (2006) there is large spike in apoptotic cels  3-4 
weeks after cutaneous injury in  normaly  healing  wounds  which can  be atributed to 
increased ECM remodeling. In the curent investigation, sample colection was performed 
in later stages of the wound healing process (4 weeks), so there would likely be a great deal 
of colagen  modification  occuring.  Colagen fiber synthesis, tissue  maturation, and 
colagen degradation by MMPs al play a significant role in dictating colagen composition 
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(Henriksen et al., 2010). Unfortunately, the curent study does not distinguish between the 
diferent types of colagen which are deposited at the wound site.  
When examining the tissue samples, there was a noticeable increase in the amount 
of myocyte regeneration in the sham and MSC treated wound tissues when compared to 
the control. Accordingly, MSCs and PRP likely have an advantageous efect on muscle 
growth.  Factors secreted from  MSCs and found in PRP including insulin-like  growth 
factor (IGF) and fibroblast growth factor (FGF) result in increased muscle proliferation 
(Lacci and Dardik, 2010).  This suggests that application of PRP may have an influence 
on healing by promoting regeneration of muscle tissue folowing injury. The application 
of MSCs did not improve muscle regeneration and PRP alone was suficient to produce 
increased myocyte regeneration  
While the present study shows an overal improvement and acceleration of healing 
processes, such as the  deposition  of  new colagen fibers, it  does  not address the 
mechanisms by which topicaly applied MSCs contribute to increased fascial regeneration 
and strength. Wounds treated with MSCs mature at an accelerated rate compared to those 
which are alowed to heal naturaly (Hefner et al., 2013). It remains unclear whether MSCs 
contribute to tissue regeneration directly through celular diferentiation or indirectly via 
paracrine factors. Atention must be paid to delivery systems which can serve to augment 
the regenerative properties of therapeutic MSC application. Ultimately, the use of this cel 
therapy is a powerful technique which holds the capacity to enrich healing of clinicaly 
problematic wounds and promote increased strength in repaired fascial tissue to prevent 
the occurence of incisional herniation folowing invasive surgery. 
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